Fulgent Genetics, Inc. FLGT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Laboratory Services | $319.81M-0.7% | $322.22M+2.2% | $315.41M+4.0% | $303.22M+3.7% | $292.45M+3.2% | |
| Therapeutic Development | $534K+19.5% | $447K+224% | $138K— | $0— | $0— | |
| Revenue by Geography | ||||||
| Non Us | $26.51M+1.5% | $26.12M+9.6% | $23.83M+1.8% | $23.41M-5.0% | $24.65M-3.9% | |
| Other Countries | $13.66M+3.4% | $13.21M+6.5% | $12.41M+0.6% | $12.33M-8.7% | $13.5M+3.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Fulgent Genetics, Inc. break its business down?
- Fulgent Genetics, Inc. (FLGT) reports revenue by business across 2 parts — Laboratory Services and Therapeutic Development. Each is extracted from the segment footnotes and tracked over time.
- Where does Fulgent Genetics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Fulgent Genetics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
